CONSOLIDATED STATEMENTS OF MEMBERS' AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Common Units	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning balance at Dec. 31, 2019			$ 344	$ (29,867)	$ (29,523)
Beginning balance (in shares) at Dec. 31, 2019	409,303
Stockholders' Deficit
Effect of reorganization (in shares)	(409,303)	409,303
Vesting of restricted common stock (in shares)		251,732
Exercise of stock options			159		159
Exercise of stock options (in shares)		28,894
Equity-based compensation expense			1,296		1,296
Net loss				(55,219)	(55,219)
Ending balance at Dec. 31, 2020			1,799	(85,086)	(83,287)
Ending balance (in shares) at Dec. 31, 2020		689,929
Stockholders' Deficit
Conversion of convertible preferred stock into common stock upon initial public offering		$ 2	222,886		222,888
Conversion of convertible preferred stock into common stock upon initial public offering (in shares)		18,398,248
Issuance of common stock upon initial public offering, net of issuance costs of $13,547		$ 1	116,358		116,359
Issuance of common stock upon initial public offering, net of issuance costs (in shares)		8,119,106
Conversion of warrant liability to equity upon initial public offering			28		28
Vesting of restricted common stock (in shares)		103,192
Exercise of stock options			283		$ 283
Exercise of stock options (in shares)		47,900			47,900
Equity-based compensation expense			4,958		$ 4,958
Net loss				(75,800)	(75,800)
Ending balance at Dec. 31, 2021		$ 3	$ 346,312	$ (160,886)	$ 185,429
Ending balance (in shares) at Dec. 31, 2021		27,358,375